Suzannah Barker shares how bedside nursing experience shapes patient-centred protocol decisions, GCP practice, and site support.
Once you’ve worked at the bedside, you don’t see clinical trials the same way again. Because every protocol begins and ends with a patient
For me, that perspective has carried through from years of working as a registered nurse in intensive care and acute settings, and into my transition to clinical research.
When we talk about clinical trials, it’s easy to default to timelines, endpoints, and data quality. These are, of course, critical. But I hope I never forget that at the centre of every study is a person, often unwell, navigating uncertainty and placing considerable trust in the healthcare practitioners and research team around them.
Patient focus isn’t abstract
In nursing, patient experience is immediate. You see when something isn’t working, when communication is unclear, when treatments create unnecessary stress, when patients are worried and start to draw away.
In clinical trials, those same issues exist, but they can be easier to miss from the top.
So bringing patient focus into studies means being deliberate about it.
We must consider: Is this realistic for a patient? Are we creating unnecessary burden? Are we setting sites up to deliver a positive patient experience, not just follow a protocol? Is this site resourced to complete the study effectively and safely for patients?
If those factors are not considered early, they often surface later as missed visits or disengagement, affecting timelines, endpoints, and data quality.
Good GCP is good patient care
GCP is often framed as compliance. We all know about the importance of documentation, potential for audits, maintaining inspection readiness.
Fundamentally, GCP is about protecting patients. It helps ensure consent is truly informed and ethical, safety events are identified and reviewed effectively, and studies are run with appropriate medical oversight. In my role, that link is direct: strong compliance means better visibility of risk and faster intervention when something is not right.
GCP compliance also has less obvious benefits for everyone involved: patients, trial sites, sponsors, and CROs.
Effective GCP helps studies run better. Sites have clearer expectations, processes are more consistent, and communication is stronger. For patients, that translates into appropriate safety and risk-benefit oversight, efficient visits, and a more supportive, well-planned experience.
And unfortunately when GCP is not maintained, the opposite happens.
The clinical experience I don't want to lose
Patients don’t experience clinical trials as protocols, datasets and endpoints. They experience them as appointments, conversations, and often difficult decisions during the most challenging parts of their lives.
GCP isn’t just about meeting a standard; it is about creating the safest and most supportive possible environment for patients.
How studies are designed, how sites are supported, and how well compliance is maintained has an impact on both patients and our clinical study reports.
We are all still in the business of patient care, just in a different way.